Cargando…
Chemoradiotherapy for locally advanced pancreatic cancer patients: is it still an open question?
Operable pancreatic cancer is characterized by a high risk of recurrence. Efforts are made to incorporate new therapies. Throughout the world there is a lack of uniform recommendations concerning the adjuvant treatment of pancreatic cancer patients, due to confusing evidence-based data. The patients...
Autores principales: | Sawicka, Emilia, Mirończuk, Anna, Wojtukiewicz, Marek Z., Sierko, Ewa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925731/ https://www.ncbi.nlm.nih.gov/pubmed/27358587 http://dx.doi.org/10.5114/wo.2016.60066 |
Ejemplares similares
-
Personalized Radiation Therapy in Cancer Pain Management
por: Sierko, Ewa, et al.
Publicado: (2019) -
Protease-activated receptors (PARs)—biology and role in cancer invasion and metastasis
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2015) -
Endothelial Protein C Receptor (EPCR), Protease Activated Receptor-1 (PAR-1) and Their Interplay in Cancer Growth and Metastatic Dissemination
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2019) -
Platelets and cancer angiogenesis nexus
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2017) -
Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2017)